01/12/2026 Written by DengyueMed
As oncology advances from conventional chemotherapy toward precision-targeted and immuno-oncology therapies, epigenetic modulators have emerged as a transformative new class of anticancer agents. Chidamide (brand name: Epidaza®), the first domestically developed original chemical new drug approved in China and the world’s first subtype-selective...
Spanish 
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek